Clinical significance of Ki-67 in patients with lung adenocarcinoma in situ complicated by type 2 diabetes

Table 1 Comparison of the clinical data among the groups

Group	Number of patients (male/female)	Age (years)	BMI (kg/m2)	Smoking (n)	TC (mmol/L)	TG (mmol/L)	HDL-C (mmol/L)
A	160 (80/80)	60.07 ± 10.47	25.1 ± 2.9	48	5.01 ± 1.11	1.64 ± 0.97	1.09 ± 0.46
B	200 (100/100)	61.40 ± 9.97	25.0 ± 3.1	60	4.69 ± 0.75b	1.27 ± 0.60b	1.18 ± 0.27
C	60 (30/30)	59.99 ± 10.32	25.2 ± 3.0	14	4.76 ± 1.12b	1.29 ± 0.60b	1.24 ± 0.28b

^bP < 0.01 vs group A.

Values are presented as the mean ± SD. Group A: Patients with acute ischemic stroke (AIS) and type 2 diabetes mellitus; Group B: Patients with AIS alone; Group C: Patients with benign pulmonary lesions. TC: Total cholesterol; TG: Total triglyceride; HDL-C: High-density lipoprotein cholesterol; BMI: Body mass index.